4//SEC Filing
Lee Sung 4
Accession 0001209191-20-060811
CIK 0001001233other
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 7:46 PM ET
Size
6.0 KB
Accession
0001209191-20-060811
Insider Transaction Report
Form 4
Lee Sung
EVP, Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2020-11-25$9.77/sh−5,042$49,260→ 88,708 total
Footnotes (2)
- [F1]Represents shares underlying the portion of the restricted stock unit grant that vested on November 25, 2020 surrendered by the Reporting Person to the Issuer for tax withholding, using the Issuer's closing stock price on November 25, 2020 of $9.77/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP, as amended").
- [F2]Includes: 9,540 shares resulting from the November 25, 2020 vesting of Reporting Person's November 25, 2019 restricted stock unit ("RSU") grant; 29,168 shares subject to such RSU grant that will vest in two remaining annual installments on November 25, 2021 and 2022, resulting in such RSU grant being vested in full on the third (3rd) anniversary of the grant date; 50,000 shares of common stock issuable upon settlement of RSUs granted to the Reporting Person on February 25, 2020. All such RSUs vest with respect to 1/3rd of the shares in each respective RSU grant in three equal annual installments over the three-year period measured from the dates of grant, subject to the Reporting Person's Continuous Service as defined in the 2018 EIP, as amended, through such dates and subject to acceleration as defined in the 2018 EIP, as amended.
Documents
Issuer
SANGAMO THERAPEUTICS, INC
CIK 0001001233
Entity typeother
Related Parties
1- filerCIK 0001793200
Filing Metadata
- Form type
- 4
- Filed
- Nov 29, 7:00 PM ET
- Accepted
- Nov 30, 7:46 PM ET
- Size
- 6.0 KB